Page last updated: 2024-09-03

neurokinin a (4-10), beta-ala(8)- and ibodutant

neurokinin a (4-10), beta-ala(8)- has been researched along with ibodutant in 1 studies

Compound Research Comparison

Studies
(neurokinin a (4-10), beta-ala(8)-)
Trials
(neurokinin a (4-10), beta-ala(8)-)
Recent Studies (post-2010)
(neurokinin a (4-10), beta-ala(8)-)
Studies
(ibodutant)
Trials
(ibodutant)
Recent Studies (post-2010) (ibodutant)
71021117

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altamura, M; Catalani, C; Catalioto, RM; Cialdai, C; Giuliani, S; Lecci, A; Maggi, CA; Meini, S; Patacchini, R; Tramontana, M; Valenti, C1

Other Studies

1 other study(ies) available for neurokinin a (4-10), beta-ala(8)- and ibodutant

ArticleYear
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    European journal of pharmacology, 2006, Nov-07, Volume: 549, Issue:1-3

    Topics: Aged; Animals; Binding, Competitive; Bronchoconstriction; Cell Membrane; CHO Cells; Colon; Cricetinae; Cricetulus; Dipeptides; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; In Vitro Techniques; Male; Mice; Middle Aged; Muscle Contraction; Neurokinin A; Peptide Fragments; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Receptors, Neurokinin-2; Swine; Thiophenes; Vasoconstriction

2006